Inventor · disambiguated record
Ling Huang
Also filed as: HUANG LING · HUANG LING-HUEI
69 granted patents·28 pending applications·1,748 citations·filing 2003–2024
99Inventor score
Top patents by PatentIndex Score
97 records- 0198US8003774B2Identification and engineering of antibodies with variant Fc regions and methods of using sameMACROGENICS INC·Filed 2008·Granted Aug 23, 2011·96 cites·52 claims
- 0298US7355008B2Identification and engineering of antibodies with variant Fc regions and methods of using sameMACROGENICS INC·Filed 2004·Granted Apr 8, 2008·361 cites·22 claims
- 0397US9822181B2Bi-specific monovalent diabodies that are capable of binding CD123 and CD3, and uses thereofMACROGENICS INC·Filed 2014·Granted Nov 21, 2017·62 cites·32 claims
- 0497US8802091B2Antibodies reactive with B7-H3 and uses thereofJOHNSON LESLIE S·Filed 2012·Granted Aug 12, 2014·54 cites·10 claims
- 0597US8216579B2Humanized FcγRIIB-specific antibodies and methods of use thereofJOHNSON LESLIE S·Filed 2010·Granted Jul 10, 2012·43 cites·16 claims
- 0697US7960512B2Identification and engineering of antibodies with variant Fc regions and methods of using sameMACROGENICS INC·Filed 2004·Granted Jun 14, 2011·161 cites·11 claims
- 0797US7786270B2Humanized FcγRIIB-specific antibodies and methods of use thereofMACROGENICS INC·Filed 2007·Granted Aug 31, 2010·55 cites·5 claims
- 0897US7521542B2Humanized FcγRIIB-specific antibodies and methods of use thereofMACROGENICS INC·Filed 2005·Granted Apr 21, 2009·105 cites·8 claims
- 0996US10131713B2HER2/neu-specific antibodies and methods of using sameMACROGENICS INC·Filed 2016·Granted Nov 20, 2018·10 cites·20 claims
- 1096US9587021B2CD3-binding molecules capable of binding to human and non-human CD3HUANG LING·Filed 2012·Granted Mar 7, 2017·45 cites·24 claims
- 1196US9150656B2Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereofJOHNSON LESLIE S·Filed 2011·Granted Oct 6, 2015·47 cites·28 claims
- 1296US8802093B2HER2/neu-specific antibodies and methods of using sameJOHNSON LESLIE S·Filed 2009·Granted Aug 12, 2014·33 cites·15 claims
- 1396US8133982B2FcγRIIB specific antibodies and methods of use thereofJOHNSON LESLIE S·Filed 2009·Granted Mar 13, 2012·54 cites·13 claims
- 1496US7351803B2CD16A binding proteins and use for the treatment of immune disordersMACROGENICS INC·Filed 2003·Granted Apr 1, 2008·78 cites·18 claims
- 1596US7112439B2Dual expression vector system for antibody expression in bacterial and mammalian cellsMACROGENICS INC·Filed 2004·Granted Sep 26, 2006·78 cites·27 claims
- 1695US9896508B2Antibodies reactive with B7-H3 and uses thereofMACROGENICS INC·Filed 2016·Granted Feb 20, 2018·8 cites·12 claims
- 1795US9469692B2HER2/neu-specific antibodies and methods of using sameMACROGENICS INC·Filed 2016·Granted Oct 18, 2016·8 cites·14 claims
- 1895US9284375B2Covalent diabodies and uses thereofJOHNSON LESLIE S·Filed 2009·Granted Mar 15, 2016·31 cites·12 claims
- 1994US10787521B2Bi-specific monovalent diabodies that are capable of binding CD123 and CD3, and uses thereofMACROGENICS INC·Filed 2017·Granted Sep 29, 2020·7 cites·18 claims
- 2094US10647768B2Multi-chain polypeptide-containing tri-specific binding moleculesMACROGENICS INC·Filed 2015·Granted May 12, 2020·19 cites·21 claims
- 2194US9243069B2HER2/neu-specific antibodies and methods of using the sameMACROGENICS INC·Filed 2014·Granted Jan 26, 2016·13 cites·9 claims
- 2294US9028815B2Identification and engineering of antibodies with variant FC regions and methods of using sameSTAVENHAGEN JEFFREY·Filed 2011·Granted May 12, 2015·24 cites·10 claims
- 2394US7618628B2CD16A binding proteins and use for the treatment of immune disordersMACROGENICS INC·Filed 2007·Granted Nov 17, 2009·22 cites·23 claims
- 2493US11111299B2CD3-binding molecules capable of binding to human and non-human CD3MACROGENICS INC·Filed 2018·Granted Sep 7, 2021·3 cites·31 claims
- 2593US9441049B2Antibodies reactive with B7-H3 and uses thereofMACROGENICS INC·Filed 2014·Granted Sep 13, 2016·10 cites·11 claims
- 2693US9296816B2Covalent diabodies and uses thereofJOHNSON LESLIE S·Filed 2006·Granted Mar 29, 2016·18 cites·36 claims
- 2793US8951517B2Identification and engineering of antibodies with variant Fc regions and methods of using sameMACROGENICS INC·Filed 2013·Granted Feb 10, 2015·19 cites·15 claims
- 2893US8795667B2Compositions for the prevention and treatment of smallpoxJOHNSON LESLIE S·Filed 2008·Granted Aug 5, 2014·13 cites·19 claims
- 2993US7572456B2Humanized antibodies against West Nile Virus and therapeutic and prophylactic uses thereofMACROGENICS INC·Filed 2005·Granted Aug 11, 2009·21 cites·19 claims
- 3092US10150812B2CD3-binding molecules capable of binding to human and non-human CD3MACROGENICS INC·Filed 2017·Granted Dec 11, 2018·9 cites·28 claims
- 3192US10093738B2Covalent diabodies and uses thereofMACROGENICS INC·Filed 2016·Granted Oct 9, 2018·7 cites·15 claims
- 3292US9695236B2BCR-complex-specific antibodies and methods of using sameMACROGENICS INC·Filed 2015·Granted Jul 4, 2017·11 cites·19 claims
- 3392US7838635B2CD16A binding proteins and use for the treatment of immune disordersMACROGENICS INC·Filed 2007·Granted Nov 23, 2010·17 cites·19 claims
- 3492US7422696B2Multicomponent nanorodsUNIV NORTHWESTERN·Filed 2005·Granted Sep 9, 2008·28 cites·8 claims
- 3591US11028183B2HER2/neu-specific antibodies and methods of using sameMACROGENICS INC·Filed 2018·Granted Jun 8, 2021·3 cites·38 claims
- 3691US9889197B2Covalently-associated diabody complexes that possess charged coil domains and that are capable of enhanced binding to serum albuminJOHNSON LESLIE S·Filed 2011·Granted Feb 13, 2018·13 cites·12 claims
- 3791US9714296B2Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereofMACROGENICS INC·Filed 2015·Granted Jul 25, 2017·7 cites·27 claims
- 3890US9714295B2Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereofMACROGENICS INC·Filed 2015·Granted Jul 25, 2017·6 cites·27 claims
- 3990US8784808B2FcγRIIB specific antibodies and methods of use thereofJOHNSON LESLIE S·Filed 2012·Granted Jul 22, 2014·13 cites·25 claims
- 4090US8445645B2Identification and engineering of antibodies with variant Fc regions and methods of using sameSTAVENHAGEN JEFFREY·Filed 2011·Granted May 21, 2013·15 cites·8 claims
- 4189US11685781B2Variant CD3-binding domains and their use in combination therapies for the treatment of diseaseMACROGENICS INC·Filed 2019·Granted Jun 27, 2023·4 cites·33 claims
- 4289US11384149B2Bi-specific monovalent Fc diabodies that are capable of binding CD32B and CD79b and uses thereofMACROGENICS INC·Filed 2019·Granted Jul 12, 2022·4 cites·13 claims
- 4389US10683364B2Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereofMACROGENICS INC·Filed 2017·Granted Jun 16, 2020·3 cites·20 claims
- 4489US8993730B2BCR-complex-specific antibodies and methods of using sameMACROGENICS INC·Filed 2013·Granted Mar 31, 2015·10 cites·33 claims
- 4589US8785599B2FcγRIIB—specific antibodies and methods of use thereofJOHNSON LESLIE S·Filed 2007·Granted Jul 22, 2014·11 cites·20 claims
- 4689US7906327B2Dual expression vector system for antibody expression in bacterial and mammalian cellsMACROGENICS INC·Filed 2006·Granted Mar 15, 2011·9 cites·22 claims
- 4789US2024409661A1Antibodies Reactive with B7-H3, Immunologically Active Fragments Thereof and Uses ThereofMACROGENICS INC·Filed 2024·Application pending·0 cites
- 4888US8669349B2BCR-complex-specific antibodies and methods of using sameJOHNSON LESLIE·Filed 2009·Granted Mar 11, 2014·21 cites·13 claims
- 4987US10093739B2Covalent diabodies and uses thereofMACROGENICS INC·Filed 2016·Granted Oct 9, 2018·2 cites·13 claims
- 5087US2025122284A1CD3-Binding Molecules Capable of Binding to Human and Non-Human CD3MACROGENICS INC·Filed 2024·Application pending·0 cites
Showing the top 50 of 97 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ling Huang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →